(Q44294516)

1 December 2017

Visceral fat and liver fat are independent predictors of metabolic risk factors in men. (English)

1 reference

1 December 2017

4

Steven N Blair

1 reference

1 December 2017

3

Timothy S Church

1 reference

1 December 2017

Thanh-Binh Nguyen-Duy

series ordinal

1

1 reference

PubMed ID

12554597

1 December 2017

Milton Z Nichaman

series ordinal

2

1 reference

PubMed ID

12554597

1 December 2017

Robert Ross

series ordinal

5

1 reference

1 December 2017

28 January 2003

1 reference

American Journal of Physiology - Endocrinology and Metabolism

1 December 2017

1 reference

1 December 2017

284

1 reference

1 December 2017

6

1 reference

1 December 2017

E1065-71

1 reference

Nonalcoholic fatty liver disease

1 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Health consequences of visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

In vivo human lipolytic activity in preperitoneal and subdivisions of subcutaneous abdominal adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Metabolic and nutritional considerations in nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Fatty liver--an additional and treatable feature of the insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Hepatic lipid metabolism in severe human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Lipolysis in adipocytes isolated from deep and superficial subcutaneous adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Detection of subclinical cardiovascular disease: the emerging role of electron beam computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Abdominal adiposity and insulin resistance in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Effect of prolonged exercise training without weight loss on high-density lipoprotein metabolism in overweight men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Determinants of insulin-stimulated glucose disposal in middle-aged, premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Peroxisome proliferator-activated receptor gamma and metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

Insulin-regulated transcription factors: molecular link between insulin resistance and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2002

10.1152/AJPENDO.00442.2002

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

12554597